Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New orally bioavailable TTK inhibitor described

April 12, 2012

Novel ApoA-I-mimetic peptide shows promise as atherosclerosis drug

April 11, 2012

Mutant caveolin-1-derived peptide reduces atherosclerotic lesions

April 11, 2012

Takeda reports on efforts to develop new HER2/EGFR kinase inhibitors

April 11, 2012

New HCV NS3/NS4A inhibitor characterized

April 11, 2012

Bayer Healthcare presents new oral selective PI3K inhibitor

April 11, 2012

Preclinical and first clinical data disclosed on MLN-2480

April 11, 2012

Novel anticancer nanomedicine shows promise in clinical trial

April 10, 2012

Amgen presents first preclinical data on novel anticancer drug

April 10, 2012

ARMOR1 trial assesses safety of galeterone in prostate cancer

April 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...